Phase 2 Metastatic Non Small Cell Lung Cancer trials recruiting now

All Metastatic Non Small Cell Lung Cancer trials, every phase

Other phases for Metastatic Non Small Cell Lung Cancer

Phase 2 Metastatic Non Small Cell Lung Cancer trials

• A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT07154290 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
  NCT04614103 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 71 locations
• Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
  NCT04410796 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
  NCT04613596 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 770 locations
• Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
  NCT06731413 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Safety and Efficacy of OBX-115 in Advanced Solid Tumors
  NCT06060613 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.